Lineage Cell Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Lineage Cell Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2017 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $8.87M, a 26.3% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $8.87M -$3.17M -26.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $45K -$31.3M -99.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $50K -$46.5M -99.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $9.86M -$31.7M -76.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $12M +$10.9M +926% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $31.4M +$29.5M +1566% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $46.5M +$43.9M +1678% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $41.6M +$37.3M +869% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.17M -$5.57M -82.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.88M -$4.27M -69.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.62M -$6.36M -70.9% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $4.3M -$1.19M -21.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $6.75M -$830K -11% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $6.15M -$9.78M -61.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $8.98M -$12.2M -57.7% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $5.48M -$15.8M -74.3% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $7.58M -$902K -10.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $15.9M +$6.85M +75.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $21.2M +$14.1M +197% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $21.3M +$19.3M +981% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $8.48M +$6.53M +335% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $9.09M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $7.15M +$5.82M +435% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $1.97M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $1.95M Jun 30, 2018 10-Q 2018-08-02
Q4 2017 $1.34M Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.